Author:
Zimmermann Julia S. M.,Gross Charlotte,Kaya Askin C.,Stotz Lisa,Raczeck Paul,Kranzhöfer Nicole,Nistor Adriana,Radosa Marc P.,Solomayer Erich-Franz,Radosa Julia C.
Publisher
Springer Science and Business Media LLC
Reference3 articles.
1. Langfassung der S2k Leitlinie „Gestationsbedingte und nicht-gestationsbedingte Trophoblasterkrankungen“, Version 6.2, August 2022. https://www.awmf.org/uploads/tx_szleitlinien/032-049l_S2k_Gestationsbedingte-und-nicht-gestationsbedingte-Trophoblasterkrankungen_2022-08.pdf
2. https://www.uptodate.com/contents/initial-management-of-low-risk-gestational-trophoblastic-neoplasia?topicRef=95881&source=see_link#references
3. Breitbach GP, Sklavounos P, Veith C, Costa SD, Kuhn W, Solomayer EF, Juhasz-Boess I, Tempfer C (2019) Oral etoposide for metastatic choriocarcinoma: a case report and review of guidelines. Arch Gynecol Obstet 299(4):1115–1119